Polypharmacology, or the associations between two or more drugs producing biologicaleffects on two or more different sites of action could represent a possible therapeuticapproach for the clinical management of acute and chronic pain. The multitude and complexityof neuronal mechanisms that contribute to pain transmission provide several possible targetsfor pharmacological intervention. Thus, multitarget ligands possessing opioid-opioid ornon-opioid-opioid mechanisms of action are potential drug candidates for pain relief. In thisperspective, the past medicinal chemistry paradigm “one-target, one-disease” has been reconsideredand converted into “one-molecule, multiple targets”. Multitarget ligands in comparisonwith cocktail drugs, besides an improved analgesic effect, display a more predictablepharmacokinetic and pharmacodynamic profile coupled to a less incidence of side-effects.Thus, they ameliorate patient compliance and decrease the risk of drug-drug interactions. Inour previous review multitarget ligands with an opioid-opioid mechanism of action weredescribed. Here, we deal with multitarget ligands with opioid-non opioid mechanism of actionas potential drug candidates for the management of different pain states.
Multitarget Opioid/Non-opioid Ligands: A Potential Approach in Pain Management
Turnaturi R
Membro del Collaboration Group
;Arico GMembro del Collaboration Group
;Ronsisvalle GMembro del Collaboration Group
;Pasquinucci L;Parenti CUltimo
2016-01-01
Abstract
Polypharmacology, or the associations between two or more drugs producing biologicaleffects on two or more different sites of action could represent a possible therapeuticapproach for the clinical management of acute and chronic pain. The multitude and complexityof neuronal mechanisms that contribute to pain transmission provide several possible targetsfor pharmacological intervention. Thus, multitarget ligands possessing opioid-opioid ornon-opioid-opioid mechanisms of action are potential drug candidates for pain relief. In thisperspective, the past medicinal chemistry paradigm “one-target, one-disease” has been reconsideredand converted into “one-molecule, multiple targets”. Multitarget ligands in comparisonwith cocktail drugs, besides an improved analgesic effect, display a more predictablepharmacokinetic and pharmacodynamic profile coupled to a less incidence of side-effects.Thus, they ameliorate patient compliance and decrease the risk of drug-drug interactions. Inour previous review multitarget ligands with an opioid-opioid mechanism of action weredescribed. Here, we deal with multitarget ligands with opioid-non opioid mechanism of actionas potential drug candidates for the management of different pain states.File | Dimensione | Formato | |
---|---|---|---|
Turnaturi-MS.pdf
solo gestori archivio
Descrizione: Articolo principale
Tipologia:
Documento in Post-print
Dimensione
943.18 kB
Formato
Adobe PDF
|
943.18 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.